AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇲🇼

LOPINAVIR, RITONAVIR in Malawi

12 products registered with PMRA 0 active, 12 expired

Brand / ProductReg. No.HolderStatusExpires
KALETRA COMBINATION PRODUCT CAPSULE
CAPSULE
PMPB/PL147/26expired31 Mar 2025
LOPINAVIR-RITONAVIR 100MG/25MG CAPSULE
CAPSULE
PMPB/PL132/91expired31 Mar 2025
LOPINAVIR_RITONAVIR 100/25MG TABLET
TABLET
PMPB/PL493/10expired31 Mar 2025
ALUVIA 200/50MG TABLET
TABLET
PMPB/PL147/ 22expired31 Mar 2025
LOPINAVIR/RITONAVIR COMBINATION PRODUCT TABLET
TABLET
PMPB/PL354/8expired31 Mar 2025
ALUVIA-125 100/25MG TABLET
TABLET
PMPB/PL147/28expired31 Mar 2025
KALETRA 80/20MG SOLUTION
SOLUTION
PMPB/PL147/27expired31 Mar 2025
LOPINAVIR_&RITONAVIR 200/50MG TABLETS
TABLETS
PMPB/PL/132/84expired31 Mar 2025
LOPINAVIR&RITONAVIR_100/25 100/25MG TABLET
TABLET
PMPB/PL401/90expired31 Mar 2024
LOPINAVIR&_RITONAVIR 200MG/50MG TABLET
TABLET
PMPB/PL401/30expired31 Mar 2024
LOPINAVIR_&RITONAVIR 100/25MG TABLET
TABLET
PMPB/PL354/20expired31 Mar 2024
LOPIMUNE 200/50MG TABLET
TABLET
PMPB/PL167/126expired30 Jun 2016

LOPINAVIR, RITONAVIRPMRA Registration Details

PMRA (Malawi) has 12 registered products containing LOPINAVIR, RITONAVIR, of which 0 are currently active. Data is sourced directly from the official PMRA drug register and refreshed daily.

Track LOPINAVIR, RITONAVIR registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.

Lopinavir Ritonavir — Malawi (PMRA) | AfricaRegulatory